MarketingSherpa’s tenth annual MarketingSherpthe only email marketing conference based on proven research and science, will be held February 19-22 at the Paris Las Vegas Hotel & Casino.
Four power-packed days of hands-on training includes 25 speakers, 30 roundtable discussions and eight breakout sessions. Five tactical trainings will focus on optimizing email marketing programs, and leveraging analytics and testing to gauge results and return on investment.
To view Multimedia News Release, go to http://www.multivu.com/players/English/59419-meclabs-email-summit-2013/
Joerns Healthcare has launched the Dolphin Fluid Immersion Simulation® system that more effectively prevents and treats pressure-related injuries than other surfaces. This patented technology simulates the effect of floating in water for patients on hospital beds, stretchers, and in wheel chairs. The Dolphin technology continually adjusts to the patient’s body, promoting tissue perfusion and oxygenation, and minimizing injury related to compromised blood flow. The Dolphin is also proven to accelerate healing of advanced stage or multiple pressure ulcers, muscle flaps, skin grafts, burns and other wound conditions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58463-joerns-dolphin-fluid-immersion-simulation-system-pressure-related-injuries
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
The fight against youth tobacco use was accelerated today by Surgeon General Dr. Regina Benjamin, with the release of the Surgeon General’s Report, Preventing Tobacco Use Among Youth and Young Adults. This report details the scope, health consequences and influences that lead to youth tobacco use and proven strategies that prevent its use.
In addition, the Centers for Disease Control and Prevention’s Office on Smoking and Health will launch the Surgeon General’s Video Challenge to engage youth and young adults in developing original videos that feature one or more of the report’s findings. More information can be found at www.Challenge.gov.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54916-surgeon-general-releases-new-report-on-teen-smoking-tobacco-prevention
A new solar power system is installed in the United States every 1.6 minutes, according to the Solar Energy Industries Association (SEIA). With the number of residential solar installations expected to increase this year by 35 percent according to GTM Research, more consumers will have an opportunity to choose the best solar solution for their home, saving on electricity bills while generating clean energy. Offering a record-setting, proven solar power solution, SunPower reminds homeowners that better solar technology exists and is accessible today.
“Solar technology differs widely from brand to brand, so it’s important for consumers to consider that not all panels deliver the same amount of energy, look elegant on a roof, or are guaranteed to last as long as promised,” said Howard Wenger, SunPower president, business units. “SunPower® panels are the most efficient that homeowners can buy, and we stand behind them for a quarter century. We’re proud to hold the world-record title for efficiency.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7706151-sunpower-residential-solar-panel/
Singer songwriter Debbie Gibson will appear on the premiere episode of the fifth installment of The Celebrity Apprentice. She will play for the Kansas City charity Children International.
The Celebrity Apprentice is a reality television show where celebrities compete in weekly challenges and donate any winnings to their personal charities. Every week, the celebrity contestants will work in two teams, each under the guidance of a designated project manager, to compete in business-driven tasks around New York City, using their fame, along with their proven business acumen, to win challenges.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52273-children-international-singer-debbie-gibson-on-the-celebrity-apprentice
On September 15th, Crest and Oral-B announced the kick off of National Gingivitis Awareness Month, with a press conference in Greeley Square Park, Manhattan, featuring “White Collar” star, Tiffani Thiessen. Thiessen is helping Crest and Oral-B to bring attention to the early gum disease, gingivitis, which affects more than fifty percent of American adults¹. Along with the declaration, Crest and Oral-B are helping consumers prevent and reverse gingivitis by introducing a new member to the Crest® Pro-Health® family, Crest® Pro-Health® Clinical Gum Protection. The new, advanced formula of Clinical Gum Protection provides Crest’s highest level of protection against the plaque bacteria that can cause gingivitis and with regular use, is clinically proven to help reverse gingivitis in just four weeks.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/crestprohealth/44592/
Isle of Capri Casinos, Inc. (NASDAQ:ISLE) today announced the winners of its second charitable social media contest awarding a share of $50,000 to five local nonprofit organizations.
Southern Heritage Air Foundation - $25,000 – Tallulah, Louisiana
Family and Youth Opportunities Division - $15,000 – Clarksdale, Mississippi
Fayette Community Service Organization - $5,000 – Fayette, Mississippi
Guttenberg Gallery & Creativity Center - $2,500 – Guttenberg, Iowa
Walking In The Sun Rescue - $2,500 – Collinston, Louisiana
“With over 69,000 votes cast in Community Aces Challenge and over 200 applications to participate, our second charitable social media contest has proven to be a wonderful way to give back to the communities where we operate,” said Virginia McDowell, Isle’s president and chief executive officer.
“The 123 participating nonprofit organizations registered in January and coordinated their own individual voting campaigns which ended on April 1,” said McDowell. “This year the winners offered a wide variety of missions – from getting fit in rural Mississippi to enhancing creativity of young people in Iowa. Our first place winner is dedicated to educating people about the history and impact of aviation and our second place winner is refurbishing an old school to become a community center.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7805451-isle-of-capri-casinos-community-aces-challenge/
Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company’s noninvasive, stool DNA colorectal cancer screening test. Cologuard is the first noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers and has been proven to find 92 percent of cancers and 69 percent of the most advanced precancerous polyps in average risk patients. Cologuard, which is available through healthcare providers, offers people 50 and older at average risk for colorectal cancer an easy–to–use screening test they can do in the privacy of their own home.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7092251-fda-approve-s-exact-sciences-cologuard-screening-test-colorectal-cancer/
Studies show that more than two-thirds of aesthetically-oriented consumers are bothered by submental fullness, or “double chin.” And with social media profile images becoming more important than ever, there is interest in looking one’s best.
Submental fullness due to fat beneath the chin can impact a broad range of both men and women and because the condition can be genetic and resistant to diet and exercise. But there’s KYBELLA®, the first and only FDA-approved injectable treatment that is available by prescription only, that has been proven to improve the appearance of moderate to severe fat beneath the chin by physically destroying fat cells in the treatment area. In two pivotal clinical studies for KYBELLA®, reductions in submental fat volume were observed more frequently in the KYBELLA® treated group of 514 patients compared to the placebo group (508 patients) as measured by both clinician and patient ratings. In addition, visual and emotional impacts of submental fat (happy, bothered, self-conscious, embarrassed, looking older or overweight) were evaluated using a 6-question survey and 79% of 1 and 2-grade composite responders reported satisfaction after 12 weeks post final treatment compared with 33.6% of patients who received placebo.
To view the multimedia release go to:
http://www.multivu.com/players/English/7962051-kybella-injectable-double-chin-treatment-campaign/
www.ta65.co.za - Telomerase is an enzyme that can add DNA repeats to chromosomes and actually grow back telomere length. And now, you can activate your body’s own natural telomerase with TA-65®, the world’s first proven telomerase activator!
http://caterforhealthandfitness.shop099.com/
Do you have a desire to live a healthier life? I'm sure the answer is yes! In the world we live in today, there are so many stressors that can wreak havoc on our life, and cause our health to rapidly decline, therefore it is vital that we try to maintain our health.If you are looking for real ways to improve your Health and Fitness, what you need is a proven selection of reliable, health and fitness solutions. Start your good health experience with us today!
